Results 211 to 220 of about 118,680 (255)

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Follicle-stimulating hormone (FSH)

2018
Daniele Santi, Livio Casarini, Gary R. Marshall, Manuela Simoni   +3 more
openaire   +1 more source

Follicle-Stimulating Hormone

2019
Tom Sam, Renato de Leeuw
openaire   +1 more source

Follicle-stimulating hormone

2016
openaire   +2 more sources

Tumor board presentation of a woman with metastatic, hormone receptor‐positive, mismatch repair‐deficient endometrial cancer

Ca-A Cancer Journal for Clinicians, 2022
Jennifer A Bennett, Gini F Fleming
exaly  

Follicle Stimulating Hormone

2008
openaire   +2 more sources

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

Follicle Stimulating Hormone

2011
openaire   +2 more sources

FSH (Follicle-Stimulating Hormone)

2018
Follicle-stimulating hormone (FSH) is a glycoprotein regulating development and reproduction. In both adult fertile males and females, FSH mediates spermatogenesis and folliculogenesis, acting through its G-protein coupled receptor (FSHR). Mutations and single nucleotide polymorphisms occurring within the genes encoding the hormone beta subunit and ...
Daniele Santi, Livio Casarini, Gary R Marshall, Manuela Simoni   +3 more
openaire   +1 more source

Follicle-stimulating Hormone

2006
openaire   +2 more sources